Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-11

Clinical Trial Update: 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 comparative effectiveness trial comparing lamotrigine to fluoxetine in bipolar depression was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)
  • Lamotrigine (lamotrigine)

Snippet

Sponsor: Mayo Clinic | Conditions: Bipolar Disorder | Phase 4 | Status: TERMINATED | Results posted: 2019-06-11